| Predicted Trait | |
| Reported Trait | Malignant neoplasm of testis |
| Mapped Trait(s) | testicular carcinoma (EFO_0005088) |
| Additional Trait Information | PheCode 187.2 |
| Score Construction | |
| PGS Name | PRSWEB_PHECODE187.2_GWAS-Catalog-r2019-05-03-X187.2_PT_MGI_20200608 |
| Development Method | |
| Name | Pruning and Thresholding (P+T) |
| Parameters | LD Clumping (MAF >= 1%, r^2 <= 0.1) & P<=2.51e-11 |
| Variants | |
| Original Genome Build | GRCh37 |
| Number of Variants | 22 |
| Effect Weight Type | NR |
| PGS Source | |
| PGS Catalog Publication (PGP) ID | PGP000118 |
| Citation (link to publication) | Fritsche LG et al. Am J Hum Genet (2020) |
| Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
|---|---|---|---|
GWAS Catalog: GCST000414 Europe PMC: 19483681 |
2,165 individuals | European | NR |
GWAS Catalog: GCST000701 Europe PMC: 20543847 |
5,926 individuals | European | NR |
GWAS Catalog: GCST002022 Europe PMC: 23666240 |
5,932 individuals | European | NR |
GWAS Catalog: GCST002023 Europe PMC: 23666239 |
1,638 individuals | European | NR |
GWAS Catalog: GCST002855 Europe PMC: 25877299 |
8,013 individuals | European | NR |
GWAS Catalog: GCST003246 Europe PMC: 26503584 |
5,932 individuals | European | NR |
GWAS Catalog: GCST003247 Europe PMC: 26503584 |
5,932 individuals | European | NR |
GWAS Catalog: GCST004635 Europe PMC: 28604728 |
24,573 individuals | European | NR |
GWAS Catalog: GCST004713 Europe PMC: 28604732 |
17,528 individuals | European | NR |
| Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) | Phenotype Definitions & Methods | Age of Study Participants | Participant Follow-up Time | Additional Ancestry Description | Additional Sample/Cohort Information |
|---|---|---|---|---|---|---|---|---|
Europe PMC: 32991828 |
[
|
European | MGI | PheCode:187.2; ICD9CM:186.0, 186.9, V10.47; ICD10CM:C62, C62.0, C62.00, C62.01, C62.02, C62.1, C62.10, C62.11, C62.12, C62.9, C62.90, C62.91, C62.92 | — | — | — | — |
|
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
|---|---|---|---|---|---|---|---|---|
| PPM001288 | PSS000553| European Ancestry| 755 individuals |
PGP000118 | Fritsche LG et al. Am J Hum Genet (2020) |
Reported Trait: Malignant neoplasm of testis | OR: 1.625 [1.27, 2.079] β: 0.485 (0.126) |
AUROC: 0.625 [0.557, 0.693] | Nagelkerke's Pseudo-R²: 0.044 Brier score: 0.084 Odds Ratio (OR, top 1% vs. Rest): 6.05 [1.73, 21.2] |
age, sex, batch PCs 1-4 | Cancer PRSweb PheWAS Results: PRSWEB_PHECODE187.2_GWAS-Catalog-r2019-05-03-X187.2_PT_MGI_20200608 |
|
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
|---|---|---|---|---|---|---|---|---|
| PSS000553 | PheCode:187.2; ICD9CM:186.0, 186.9, V10.47; ICD10CM:C62, C62.0, C62.00, C62.01, C62.02, C62.1, C62.10, C62.11, C62.12, C62.9, C62.90, C62.91, C62.92 | — | [
|
— | European | — | MGI | — |